Substituted thiophene compounds as d-dopachrome tautomerase inhibitors

The present invention relates to substituted thiophene compounds and methods useful for inhibiting D-dopachrome tautomerase. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of various disorders, notably cancer, such as NSCLC, and inflammation